Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

114.03
-1.2050-1.05%
Post-market: 114.950.9235+0.81%19:30 EDT
Volume:878.99K
Turnover:100.01M
Market Cap:12.33B
PE:251.35
High:115.98
Open:114.29
Low:111.94
Close:115.23
52wk High:126.38
52wk Low:28.66
Shares:108.10M
Float Shares:96.44M
Volume Ratio:0.91
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4537
EPS(LYR):0.8200
ROE:8.23%
ROA:0.47%
PB:17.46
PE(LYR):139.05

Loading ...

Corcept Therapeutics Inc : UBS Raises to Buy From Neutral

THOMSON REUTERS
·
May 13

Corcept Therapeutics upgraded to Buy from Neutral at UBS

TIPRANKS
·
May 13

Corcept Therapeutics Raised to Buy From Neutral by UBS

Dow Jones
·
May 13

UBS Upgrades Corcept Therapeutics to Buy From Neutral, Adjusts Price Target to $72 From $44

MT Newswires Live
·
May 13

Corcept CEO Joseph Belanoff disposes 40,000 shares worth $2 million

Reuters
·
May 06

Corcept Therapeutics Signals Big Growth After Key Wins

TIPRANKS
·
May 05

Canaccord Genuity Remains a Buy on Corcept Therapeutics (CORT)

TIPRANKS
·
May 04

Corcept Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 04

Corcept Therapeutics price target raised to $75 from $60 at H.C. Wainwright

TIPRANKS
·
May 04

Corcept Therapeutics Inc. : H.c. Wainwright Raises Target Price to $75 From $60

THOMSON REUTERS
·
May 04

Is Corcept Therapeutics (CORT) Pricing Make Sense After Recent Volatility In The Share Price

Simply Wall St.
·
May 02

Corcept Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
May 02

Stock Track | Corcept Therapeutics Soars 5.33% Intraday After Piper Sandler Raises Price Target to $88

Stock Track
·
May 01

Corcept Therapeutics price target raised to $88 from $73 at Piper Sandler

TIPRANKS
·
May 01

U.S. RESEARCH ROUNDUP-Caterpillar, Textron, Wesco International

Reuters
·
May 01

Corcept Therapeutics Inc : Piper Sandler Raises Target Price to $88 From $73

THOMSON REUTERS
·
May 01

Corcept Therapeutics Swings to Loss, Says ALS Drug Didn't Meet Primary Endpoint

Dow Jones
·
May 01

Corcept Therapeutics announced 2-year OS data from Phase 2 dazucorilant study

TIPRANKS
·
May 01

Corcept Q1 revenue rises but misses analyst estimates

Reuters
·
May 01

Earnings Flash (CORT) Corcept Therapeutics Posts Q1 Per Share Loss $-0.30

MT Newswires Live
·
May 01